Pharmalittle: Dems eye MFN deals, Europe sees fewer new drugs Incoming Democratic chairs of key congressional committees have taken a new step toward investigating most-favored nation drug pricing agreements.

Pharmalittle: Dems eye MFN deals, Europe sees fewer new drugs Incoming Democratic chairs of key congressional committees have taken a new step toward investigating most-favored nation drug pricing agreements. Incoming Democratic chairs of key congressional committees have taken a new step toward investigating most-favored nation drug pricing agreements.